美国 · SEC FORM 4
Nurix Therapeutics, Inc.
NRIX · Nasdaq · CIK 0001549595 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
56 同一窗口内观察到的 Form 4 交易行
26 sales · 30 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 17,657,588
- 上期报告
- 17,976,804
- 日均成交量
- 1,776,243
- 回补天数
- 9.9
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
101 transaction lines in the latest 365-day window; 454 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Hansen Gwenn | 卖出 (S) | Common Stock | 1,452 | USD 25.00 | USD 36,300 | SEC 申报 ↗ |
| 2026-10-15 | Hansen Gwenn | 期权行权/转换 (M) | Common Stock | 1,452 | USD 1.86 | USD 2,701 | SEC 申报 ↗ |
| 2026-10-14 | GREGORY JULIA P | 卖出 (S) | Common Stock | 22,583 | USD 23.40 | USD 528,528 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Hansen Gwenn | 卖出 (S) | Common Stock | 1,452 | USD 25.00 | USD 36,300 | SEC 申报 ↗ |
| 2026-10-15 | Hansen Gwenn | 期权行权/转换 (M) | Common Stock | 1,452 | USD 1.86 | USD 2,701 | SEC 申报 ↗ |
| 2026-10-14 | GREGORY JULIA P | 卖出 (S) | Common Stock | 22,583 | USD 23.40 | USD 528,528 | SEC 申报 ↗ |
| 2026-10-14 | GREGORY JULIA P | 期权行权/转换 (M) | Common Stock | 22,583 | USD 1.86 | USD 42,004 | SEC 申报 ↗ |
| 2026-10-02 | Ring Christine | 卖出 (S) | Common Stock | 5,786 | USD 23.19 | USD 134,149 | SEC 申报 ↗ |
| 2026-10-02 | Ring Christine | 期权行权/转换 (M) | Common Stock | 5,786 | USD 8.72 | USD 50,454 | SEC 申报 ↗ |
| 2026-09-02 | Ring Christine | 卖出 (S) | Common Stock | 5,787 | USD 25.76 | USD 149,048 | SEC 申报 ↗ |
| 2026-09-02 | Ring Christine | 期权行权/转换 (M) | Common Stock | 5,787 | USD 8.72 | USD 50,463 | SEC 申报 ↗ |
| 2026-09-01 | Hansen Gwenn | 卖出 (S) | Common Stock | 1,452 | USD 25.47 | USD 36,982 | SEC 申报 ↗ |
| 2026-09-01 | Hansen Gwenn | 期权行权/转换 (M) | Common Stock | 1,452 | USD 1.86 | USD 2,701 | SEC 申报 ↗ |
| 2026-08-05 | Hansen Gwenn | 卖出 (S) | Common Stock | 4,356 | USD 25.00 | USD 108,900 | SEC 申报 ↗ |
| 2026-08-05 | Hansen Gwenn | 期权行权/转换 (M) | Common Stock | 4,356 | USD 1.86 | USD 8,102 | SEC 申报 ↗ |
| 2026-08-04 | Hansen Gwenn | 卖出 (S) | Common Stock | 4,111 | USD 24.36 | USD 100,140 | SEC 申报 ↗ |
| 2026-08-04 | van Houte Hans | 卖出 (S) | Common Stock | 4,761 | USD 24.36 | USD 115,995 | SEC 申报 ↗ |
| 2026-08-03 | Ring Christine | 卖出 (S) | Common Stock | 16,589 | USD 23.05 | USD 382,376 | SEC 申报 ↗ |
| 2026-08-03 | Ring Christine | 期权行权/转换 (M) | Common Stock | 5,787 | USD 8.72 | USD 50,463 | SEC 申报 ↗ |
| 2026-07-30 | van Houte Hans | 卖出 (S) | Common Stock | 2,845 | USD 23.38 | USD 66,516 | SEC 申报 ↗ |
| 2026-07-30 | van Houte Hans | 期权行权/转换 (M) | Common Stock | 10,180 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-30 | Ring Christine | 卖出 (S) | Common Stock | 3,847 | USD 23.38 | USD 89,943 | SEC 申报 ↗ |
| 2026-07-30 | Ring Christine | 期权行权/转换 (M) | Common Stock | 10,180 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-30 | Hansen Gwenn | 卖出 (S) | Common Stock | 3,847 | USD 23.38 | USD 89,943 | SEC 申报 ↗ |
| 2026-07-30 | Hansen Gwenn | 期权行权/转换 (M) | Common Stock | 10,180 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-02 | Ring Christine | 卖出 (S) | Common Stock | 11,008 | USD 23.56 | USD 259,348 | SEC 申报 ↗ |
| 2026-07-02 | Ring Christine | 期权行权/转换 (M) | Common Stock | 11,008 | USD 5.47 | USD 60,174 | SEC 申报 ↗ |
| 2026-06-25 | Ring Christine | 卖出 (S) | Common Stock | 28,935 | USD 20.06 | USD 580,436 | SEC 申报 ↗ |
| 2026-06-25 | Ring Christine | 期权行权/转换 (M) | Common Stock | 28,935 | USD 8.05 | USD 232,847 | SEC 申报 ↗ |
| 2026-06-25 | Hansen Gwenn | 卖出 (S) | Common Stock | 5,394 | USD 20.00 | USD 107,880 | SEC 申报 ↗ |
| 2026-06-02 | Ring Christine | 卖出 (S) | Common Stock | 8,148 | USD 16.60 | USD 135,257 | SEC 申报 ↗ |
| 2026-06-02 | Ring Christine | 期权行权/转换 (M) | Common Stock | 3,422 | USD 1.86 | USD 6,365 | SEC 申报 ↗ |
| 2026-05-05 | van Houte Hans | 卖出 (S) | Common Stock | 14,055 | USD 16.60 | USD 233,381 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NRIX |
| CIK | 0001549595 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 454 transaction lines from 2020-07-28 to 2026-10-15 0 P purchase lines · 194 S sale lines · 260 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.